Holen Sie sich die Stockscreener-App
0.7801
0.99%
-0.0077
Schlusskurs vom Vortag:
$0.7878
Offen:
$0.7901
24-Stunden-Volumen:
43,576
Relative Volume:
0.01
Marktkapitalisierung:
$2.48M
Einnahmen:
$8.77M
Nettoeinkommen (Verlust:
$-19.05M
KGV:
-0.000348
EPS:
-2243.7675
Netto-Cashflow:
$-11.60M
1W Leistung:
+5.55%
1M Leistung:
-47.65%
6M Leistung:
-98.27%
1J Leistung:
-99.49%
1-Tages-Spanne:
$0.771
$0.8097
1-Wochen-Bereich:
$0.7112
$0.829
52-Wochen-Spanne:
$0.7112
$183.05
Nuwellis Inc Stock (NUWE) Company Profile
Firmenname
Nuwellis Inc
Sektor
Branche
Telefon
952-345-4200
Adresse
12988 VALLEY VIEW ROAD, EDEN PRAIRIE
Compare NUWE vs ABT, MDT, SYK, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NUWE
Nuwellis Inc
|
0.7801 | 2.50M | 8.77M | -19.05M | -11.60M | -2,243.77 |
ABT
Abbott Laboratories
|
106.17 | 182.59B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
92.84 | 118.18B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
272.97 | 106.03B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
45.62 | 65.19B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.51 | 49.99B | 6.30B | 1.07B | 1.09B | 1.8406 |
Nuwellis Inc Stock (NUWE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-07-29 | Eingeleitet | ROTH MKM | Buy |
Nuwellis Inc Aktie (NUWE) Neueste Nachrichten
Nuwellis Q2FY26 Results: Gross margin expands to 76%, cash runway extends - scanx.trade
Cash could last into Q3 2027 after Nuwellis shifted production to an outside manufacturer - Stock Titan
Nuwellis Inc (NASDAQ: NUWE) Share Price, NUWE Stock News, NUWE Share Price & Updates - Kalkine
Nuwellis, Inc. Announces First Quarter 2026 F - Moomoo
NUWE|Nuwellis Inc|Price:0.889|Chg%:-0.100 - TradingKey
Nuwellis, Inc. SEC Filing (Aug 27, 2026) - Stock Titan
NUWE Stock Slides As Nuwellis Strikes New Pediatric Deals - timothysykes.com
Nuwellis posts updated investor presentation highlighting Aquadex growth, 20% H1 revenue rise - tradingview.com
NUWE Stock Eyes Growth As Nuwellis Expands Aquadex Platform - StocksToTrade
Nuwellis enters co-promotion deal for cardiac monitoring device By Investing.com - Investing.com Nigeria
Nuwellis Expands Critical Care Portfolio Through Strategic Commercial Agreement with Atrility Medical - The Manila Times
NUWE Should I Buy - intellectia.ai
Nuwellis study shows epoprostenol safe for pediatric Aquadex therapy - scanx.trade
Nuwellis (NUWE) Momentum: Posts a 4.27% Loss to $1.12; Level Watch: the Price Remains Bounded by the Supplied Support and Resistance in the Latest ReadingAdvance Decline Line - vinanet.vn
Nuwellis (NUWE) Technicals: Slides 1.68% to $1.17 on the Day; Technical Setup: the $1.11 to $1.23 Range Remains in Focus under the Current SnapshotSuperTrend - dars.gov.et
Armistice Capital (NUWE) trims Nuwellis ownership to a 4.99% disclosed stake - Stock Titan
Nuwellis Inc (NUWE) (Q2 2026) Earnings Call Highlights: Revenue Surges 14% and Installed Base Expands - GuruFocus
Nuwellis Inc (NUWE) (Q2 2026) Earnings Call Highlights: Revenue Surges 14% and Installed Base ... - Yahoo Finance UK
Nuwellis Posts 14% Revenue Jump in Q2 2026, Misses on EPS - AlphaStreet
Nuwellis, Inc. (NASDAQ: NUWE) lifts Q2 2026 revenue and margin but stays unprofitable - Stock Titan
Nuwellis Reports Q2 2026: Revenue $2.0M, Gross Margin 76%, Net Loss $4.8M - TradingView
Nuwellis (NASDAQ: NUWE) boosts revenue, flags going concern and Nasdaq risks - Stock Titan
Nuwellis Q2 Results: Revenue Up 14% YoY, Gross Margin Expands To 76% - scanx.trade
Earnings call transcript: Nuwellis posts higher revenue in Q2 2026 as loss narrows - Investing.com Nigeria
NUWE: Q2 revenue up 14% year-over-year, gross margin at 76%, and net loss reduced to $4.8 million - TradingView
Transcript : Nuwellis, Inc., Q2 2026 Earnings Call, Aug 13, 2026 - marketscreener.com
Nuwellis Q2 2026 Earnings Call Transcript - Benzinga
Q2 2026 Nuwellis Inc Earnings Call Transcript - GuruFocus
Nuwellis Reports Second Quarter 2026 Financial Results and Business Highlights Focused on Double Digit Revenue Growth and Expanded Gross Margin - marketscreener.com
BRIEF-Nuwellis Q2 EPS USD -26.64 - TradingView
Press Release: Nuwellis Reports Second Quarter 2026 Financial Results and Business Highlights Focused on Double Digit Revenue Growth and Expanded Gross Margin - Moomoo
Nuwellis, Inc. (NUWE) stock price, news, quote and history - Yahoo Finance UK
NUWE Q2'26 Earnings: EPS estimate is (23.80) USD - TradingView
Nuwellis partners with Philips Capsule to connect Aquadex platform to hospital EHR systems - Bitget
Nuwellis Announces Digital Transformation Program for Aquadex SmartFlow System with Philips Capsule Integration - Quiver Quantitative
Nuwellis Accelerates Digital Transformation of the Aquadex® Platform with EHR Connectivity and Enhanced User Interface - The Manila Times
Nuwellis Announces Digital Transformation of the Aquadex Smartflow System with Ehr Connectivity and Enhanced User Interface - marketscreener.com
NUWE Q1 2026 Earnings: Massive EPS Miss Triggers 4.7% Share DeclineEPS Growth Report - vinanet.vn
Q&A: Building the next generation of cardiorenal care: An interview with Nuwellis - Digital Journal
Certain Common Stock of Nuwellis, Inc. are subject to a Lock-Up Agreement Ending on 8-AUG-2026. - marketscreener.com
Orca Capital (NUWE) discloses 7.0% Nuwellis ownership and warrant blocker - Stock Titan
Certain Stock Options of Nuwellis, Inc. are subject to a Lock-Up Agreement Ending on 8-AUG-2026. - marketscreener.com
Nuwellis appoints Dale Brady as principal R&D engineer By Investing.com - Investing.com UK
Nuwellis, Inc. (NUWE) investors detail 4.7% warrant-based ownership stake - Stock Titan
Nuwellis appoints Dale Brady as principal R&D engineer - Investing.com
Medical Device Engineer With More Than 25 Years' Experience Joins Nuwellis - Stock Titan
NUWE Q2'26 Earnings: revenue estimate is 2.42M USD - tradingview.com
Nuwellis Strengthens Product Development Organization with Appointment of Dale Brady as Principal R&D Engineer - Barchart.com
Nuwellis appoints Dale Brady principal R&D engineer - Bitget
Nuwellis (NUWE) investor reports 6.2% stake via shares and capped warrants - Stock Titan
Nuwellis, Inc. Announces Appointment of Dale Brady to Principal R&D Engineer - marketscreener.com
Finanzdaten der Nuwellis Inc-Aktie (NUWE)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.72%
0.63%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):